Last reviewed · How we verify
S-ketamine infusion outpatient setting — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
S-ketamine infusion outpatient setting (S-ketamine infusion outpatient setting) — Erasmus Medical Center.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| S-ketamine infusion outpatient setting TARGET | S-ketamine infusion outpatient setting | Erasmus Medical Center | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- S-ketamine infusion outpatient setting CI watch — RSS
- S-ketamine infusion outpatient setting CI watch — Atom
- S-ketamine infusion outpatient setting CI watch — JSON
- S-ketamine infusion outpatient setting alone — RSS
Cite this brief
Drug Landscape (2026). S-ketamine infusion outpatient setting — Competitive Intelligence Brief. https://druglandscape.com/ci/s-ketamine-infusion-outpatient-setting. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab